$BCTX Income Statement | Understand Stock

Login

Ask AI

$BCTX

$3.50 +$0.06 (1.89%) Close

$BCTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Jul 31, 2025	FY2024 12 months to Jul 31, 2024	FY2023 12 months to Jul 31, 2023	FY2022 12 months to Jul 31, 2022
Operating expenses:
Research and development expenses
General and administrative expenses
Total operating expenses
Operating loss
Financial expenses, net
Financial income (expenses), net
Change in fair value of the warrant liability
Share of loss on equity investment
Net loss for the year
Net loss attributable to non-controlling interest
Net loss for the year attributable to BriaCell
Net loss per share attributable to BriaCell - basic
Net loss per share attributable to BriaCell - diluted
Weighted average number of shares (*) used in computing net loss per share attributable to ordinary shareholders, basic
Weighted average number of shares (*) used in computing net loss per share attributable to ordinary shareholders, diluted

Loading...

Comments